MAPT and early-onset autosomal dominant Alzheimer disease: It has been suggested that plasma levels of pT181-Tau may show a significant diagnostic value, in order to discriminate Alzheimer’s disease from other neurodegenerative disorders and AUCs as high as 0.94–0.98 have been described [10,28].